<?xml version="1.0" encoding="UTF-8"?>
<ref id="B92-pathogens-09-00042">
 <label>92.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Gaudinski</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>Houser</surname>
    <given-names>K.V.</given-names>
   </name>
   <name>
    <surname>Morabito</surname>
    <given-names>K.M.</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Yamshchikov</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Rothwell</surname>
    <given-names>R.S.</given-names>
   </name>
   <name>
    <surname>Berkowitz</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Mendoza</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Saunders</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Novik</surname>
    <given-names>L.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Safety, Tolerability, and Immunogenicity of Two Zika Virus DNA Vaccine Candidates in Healthy Adults: Randomised, Open-Label, Phase 1 Clinical Trials</article-title>
  <source>Lancet</source>
  <year>2018</year>
  <volume>391</volume>
  <fpage>552</fpage>
  <lpage>562</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(17)33105-7</pub-id>
  <pub-id pub-id-type="pmid">29217376</pub-id>
 </element-citation>
</ref>
